Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

FDA Warns Of Potential Risk From Hologic Soft Tissue Devices

FDA warns of complications with Hologic's soft tissue medical devices, urging vigilance and reporting.

FDA approves new drug for food allergies

FDA approves new drug for food allergies

"We've literally overnight doubled the amount of options we have to manage this disease"

Black Americans need tobacco substitutes

Black Americans need tobacco substitutes

The decades-long failure to curb cigarette addiction reveals a painful legacy of deception towards Black Americans

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Pharma Stocks to Anchor Your Portfolio

The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio…

Beware smartwatches that claim to monitor blood sugar without skin prick, FDA says

The Food and Drug Administration has warned consumers against using "smart" devices that are marketed to measure blood sugar without piercing the skin.

DEA Shuts Down Drug Factory Even as Adderall Shortage Persists

The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.

Jumpstart Your Portfolio With These 3 Biotech Stocks

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

inkl

Read news from The Economist, FT, and more,
with one subscription

This Could Be the Next Blockbuster Drug Stock to Buy

This Could Be the Next Blockbuster Drug Stock to Buy

Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio.

Trump's quiet federal abortion ban plot

Trump's quiet federal abortion ban plot

Trump "likes the idea of a 16-week national abortion ban" but wants to keep it quiet, NY Times reports

Experimental Brain Implant Shows Promise In Treating Depression

Experimental Brain Implant Shows Promise In Treating Depression

Learn about Deep Brain Stimulation (DBS) implant for depression treatment, offering hope and relief for patients like Emily Hollenbeck.

3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven'

3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven'

As Tesla stock continues to underperform - now down more than 22% year-to-date - here are 3 mega-cap companies worthy of replacing the beleaguered EV giant in the elite group of mega-cap stocks known as the Magnificent Seven.

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA warns consumers about potential health risks of using smartwatches for blood glucose monitoring. Stay informed for accurate diabetes management.

FDA approves 1st-of-its-kind treatment for severe food allergies

FDA approves 1st-of-its-kind treatment for severe food allergies

The FDA has approved the first drug that can reduce the severity of multiple food allergies at once.

Supreme Court Denies Red State Effort to Intervene in Mifepristone Case

The Court also rejects a late-filed amicus briefs from the American Bar Association, but accepts one from former FDA Commissioners.

Get all your
news in one place.

100’s of premium titles.
One news app.

1st frostbite drug approved by FDA after successful clinical trial

A drug called Aurlumyn has been approved to treat severe frostbite in the U.S. after a successful clinical trial.

Elon Musk's Neuralink has concerning lack of transparency and could be vulnerable to hacking, ethicists warn

Brain-computer interfaces have the potential to transform some people's lives, but they raise a host of ethical issues, too.

FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know

Xolair, a medication initially designed for asthma, has been approved for treating food allergies to prevent severe reactions.

FDA approves a drug to treat severe food allergies, including milk, eggs and nuts

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

Get all your
news in one place.

100’s of premium titles.
One news app.

The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese

Health officials reported 10 cases of E. coli infection, adding that the number of people sick is likely "much higher." Those cases were from California, Colorado, Texas and Utah.

FDA approves first cell therapy to treat aggressive forms of melanoma

Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.

Pharma Stocks Analysis: Grab, Hold, or Sell?

Despite economic pressures and intensified competition, government incentives and drug innovations are fueling growth in the pharma sector. So, let us delve into the analysis of leading pharma stocks Bristol-Myers Squibb (BMY), Collegium Pharmaceutical (COLL), Pfizer (PFE), and Vaxcyte (PCVX), assessing whether to Grab, Hold, or Sell the stocks amid…

FDA approves first-ever drug to treat severe frostbite and "prevent lifechanging amputation of fingers or toes"

Frostbite is an injury to the skin caused when the skin and its underlying tissues freeze, preventing blood, oxygen and nutrients from reaching the affected areas

International Business Times

Mailed Abortion Pills Found To Be Safe Ahead Of US Ruling

Abortions administered as pills sent in the mail are just as safe and effective as those provided in person, a US study said Thursday ahead of a Supreme Court ruling on restricting the medication.

Abortion pills that patients got via telehealth and the mail are safe, study finds

The study looks at 6,000 patients who got abortion pills after an online appointment. It found that 99.7% of those abortions were not followed by any serious adverse events.

Telehealth abortions are as safe and effective as in-person, large study shows

An analysis of more than 6,000 telehealth abortion recipients in the U.S. suggests that receiving the abortion drugs via a virtual doctor's appointment is as safe and effective as doing so in person.

1 … 90 91 92 93

People

161,500 stories

Kritika SarmahHer

Jonathan Mitchell

Neha PanjwaniFrom

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Republican Party

the Supreme Court

Planned Parenthood

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

332,073 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play